The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.

@article{Gleason2016TheRA,
  title={The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.},
  author={Thomas G. Gleason and John T. Schindler and David H Adams and Michael J. Reardon and Neal S. Kleiman and Louis R. Caplan and John V. Conte and George Michael Deeb and Gillian Hughes and Sharla Chenoweth and Jeffrey J. Popma},
  journal={The Journal of thoracic and cardiovascular surgery},
  year={2016},
  volume={152 1},
  pages={85-96}
}
OBJECTIVES This study was designed to characterize the incidence of new clinically detectable neurologic events, or any comparative change in indices of higher cognitive function following transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) within the framework of a prospective, randomized clinical trial for high-risk patients. METHODS High-risk patients (predicted SAVR mortality 15%) with severe aortic stenosis (n = 750) were randomized 1:1 to TAVR or… CONTINUE READING
3 Citations
30 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Similar Papers

Loading similar papers…